Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enyo Pharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10942
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to identify key cellular proteins controlling virus replication. It has constructed a database made up of a library of virus derived peptides for the discovery of new antiviral drugs. Enyo Pharma also carries out hits identification and drug candidate’s identification for viral infections, among others. The company has collaborations with the Infectiology Center of Lyonbiopole, Jean Merieux BSL-4 Laboratory and other international academic groups. Enyo Pharma is headquartered in Lyon, France.

Enyo Pharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Partnerships 13
Enyo Pharma Enters into Agreement with Poxel 13
Licensing Agreements 14
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA – Key Competitors 16
Enyo Pharma SA – Key Employees 17
Enyo Pharma SA – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
May 11, 2017: ENYO Pharma Strengthens Its Business Team to Support International Growth 19
Clinical Trials 20
Oct 26, 2017: ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials 20
Jun 13, 2017: ENYO Pharma Announces Successful Completion of EYP001 First in Man Phase 1 Study 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Enyo Pharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Enyo Pharma Enters into Agreement with Poxel 13
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA, Key Competitors 16
Enyo Pharma SA, Key Employees 17

List of Figures
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banco Espirito Santo, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco Espirito Santo, S.A. Merg …
  • Great Western Bancorp Inc.:企業の戦略・SWOT・財務情報
    Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • NIKE, Inc.:企業の戦略・SWOT・財務分析
    SummaryNIKE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • JX Holdings, Inc. (5020):企業の財務及び戦略的SWOT分析
    Summary JX Holdings, Inc. (JX Holding) is an energy company that offers development in energy, resources, and materials. The company operates through divisions that include oil and energy, oil and gas exploration, and mining and metals. Its mining and metals division offers products such as cathode …
  • University of Mississippi:企業のM&A・提携動向(医療分野)
    Summary University of Mississippi (UOM) is an educational service provider that provides various education and research programs. The university offers undergraduate and graduate courses and research programs. It provides programs in the fields of applied science, business administration, engineerin …
  • Tso3 Inc (TOS):企業のM&A・提携動向(医療機器分野)
    Summary Tso3 Inc (Tso3) is a medical device company that develops, manufactures and markets temperature sterilization systems. The company’s products comprise Sterizone VP4 Sterilizer and Sterizone 125L+Sterilizer. Its Sterizone VP4 Sterilizer is a dual sterilant, low-temperature sterilization syste …
  • TransGlobe Energy Corporation (TGL):企業の財務及び戦略的SWOT分析
    Summary TransGlobe Energy Corporation (TransGlobe) is an independent international upstream oil and gas company that explores, develops and produces crude oil and natural gas. The company has oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. TransGlobe has inter …
  • Aerie Pharmaceuticals Inc (AERI):企業のM&A・提携動向(医療分野)
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates include Rhopressa, a once-daily eye drop which is used for the reduc …
  • Waste Management, Inc. (WM)(エネルギー分野):企業M&A動向
    Summary Waste Management, Inc. (Waste Management) is a provider of waste management environmental services. The company through its subsidiaries offers a wide range of waste management services. It offers complete services for the management and reduction of waste at each stage from collection to di …
  • Parmalat S.p.A.:企業の戦略・SWOT・財務分析
    Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chambal Fertilisers and Chemicals Limited (CHAMBLFERT):企業財務及び戦略的SWOT分析
    Summary Chambal Fertilisers and Chemicals Limited (CFCL) is a chemical company that manufactures agro-chemicals. The company supplies urea and other agri-inputs including murate of potash, di-ammonium phosphate, single super phosphate, pesticides and seeds. It provides crop nutrients, seeds, crop pr …
  • JCB Co., Ltd.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "JCB Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a s …
  • The National Fostering Agency:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The National Fostering Agency M …
  • eBASE Co., Ltd. (3835):企業概要、財務及び戦略的SWOT分析
    Summary eBASE Co., Ltd. (eBASE) is an information technology company. The company develops and markets package software products. Its products include eBASE basic software, eBASEserver software-only option, e-software, industry-specific software and optional software. eBASE provides services such as …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務及び戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is a geoservices provider that explores workflow and working with seismic, petrophysical, and geologic data. It gathers controlled source electromagnetic data and conduct modeling, integration and interpretation. The company utilizes its electromagnetic …
  • Providence Resources plc (PZQA):企業のM&A・提携動向(石油・ガス分野)
    Summary Providence Resources plc (Providence Resource) is an upstream oil and gas company that explores and develops hydrocarbon assets. The company has projects in Ireland and UK including Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's channel basin, and others …
  • Owens‑Illinois, Inc.:企業の戦略・SWOT・財務情報
    Owens‑Illinois, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens‑Illinois, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MTY Food Group Inc.:戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Canadian Real Estate Investment Trust (REF.UN):企業の財務・戦略的SWOT分析
    Summary Canadian Real Estate Investment Trust (CREIT) is a real estate service provider that offers real estate investment services. The company offers services such as real estate management, investment, development, buying, selling, renting, leasing, and real estate operations services. It also pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆